Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Advances Crofelemer for Rare Gastrointestinal Disorders
    Jaguar Advances Crofelemer for Rare Gastrointestinal Disorders

    28 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-28/jaguar-health-research-in-ethnobotanical-medicine-helps-advance-crofelemer-development-for-genetical

    PHARMIWEB
    28 May 2026
    Share Share
    Jaguar Health's Crofelemer Trial Continues in Pediatric MVID
    Jaguar Health's Crofelemer Trial Continues in Pediatric MVID

    19 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-19/jaguar-health-announces-active-treatment-only-continuation-of-pivotal-multicenter-clinical-trial-in

    PHARMIWEB
    19 May 2026
    Share Share
    Jaguar Health Announces Statistically Significant Results
    Jaguar Health Announces Statistically Significant Results

    29 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-29/jaguar-health-announces-statistically-significant-results-from-effectiveness-trial-of-crofelemer-fd

    PHARMIWEB
    29 Apr 2026
    Share Share
    AI Boosts Jaguar Health's Crofelemer for Rare Disease Therapy
    AI Boosts Jaguar Health's Crofelemer for Rare Disease Therapy

    13 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-13/artificial-intelligence-ai-platforms-could-enhance-jaguar-healths-development-and-anticipated-com

    PHARMIWEB
    13 Apr 2026
    Share Share
    Jaguar Health Completes Trial Supporting Crofelemer FDA Bid
    Jaguar Health Completes Trial Supporting Crofelemer FDA Bid

    08 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-08/jaguar-health-completes-effectiveness-trial-to-support-fda-approved-crofelemer-for-treatment-of-chem

    PHARMIWEB
    08 Apr 2026
    Share Share
    Napo Pharmaceuticals Co-Sponsoring Gastroenterology Conference
    Napo Pharmaceuticals Co-Sponsoring Gastroenterology Conference

    02 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-02/jaguar-health-family-company-napo-pharmaceuticals-co-sponsoring-pediatric-gastroenterology-conferenc

    PHARMIWEB
    02 Apr 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.